Jun 07, 2023 / 01:30PM GMT
Andrew Tsai - Jefferies - Analyst
All right. We're going to get started with the next session. I'm Andrew Tsai, Senior Biotech Analyst here at Jefferies. And it's my pleasure to have the Xenon team joining me today.
Ian Mortimer, CEO, President; Sherry Aulin, CFO. Welcome both of you.
Ian Mortimer - Xenon Pharmaceuticals Inc. - President & CEO
Thank you, Andrew.
Sherry Aulin - Xenon Pharmaceuticals Inc. - CFO
Thank you, Andrew.
Andrew Tsai - Jefferies - Analyst
So, for those in the audience who might not be as familiar with Xenon story, Ian, Sherry, could you give us a brief overview about your company? There have been some positive developments over the past couple of years. And then maybe talk about the catalysts we can expect over the coming year or two.
Ian Mortimer - Xenon Pharmaceuticals Inc. - President & CEO
Sure. Happy to. And thanks for hosting us today. We appreciate it. So I'll provide a little bit of
Xenon Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers